Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth by Steve Jones March 7, 2024March 7, 2024 Bioxyne was hit with an impairment charge of A$11.5 million in the first half of FY24 […]
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne by Martin Lane and Steve Jones September 4, 2023September 4, 2023
Wellnex Life snaps up topical pain relief brand to complement medicinal cannabis strategy by Martin Lane May 29, 2023May 29, 2023
Company news: Wellnex Life; Creso Pharma; MGC Pharma; Zelira Therapeutics by Martin Lane March 16, 2023March 16, 2023
Company news: Releaf Group; Bod; Wellnex Life; MGC Pharma; MediCann Health by Martin Lane October 27, 2022October 27, 2022
Company news: Bod Australia; Cann Group; MediCann Health; MGC Pharma; Wellnex Life by Steve Jones and Martin Lane October 5, 2022August 14, 2023
Company news: Creso Pharma; Wellnex Life; Zyus Life Sciences; Emyria; MGC Pharma; Rua Bioscience by Martin Lane July 21, 2022July 21, 2022
Company news: Wellnex Life; Incannex; Tetra Bio-Pharma; Zelira by Martin Lane June 8, 2022June 9, 2022